NOVOPHAGE
Novophage is providing the biological solutions for industrial infrastructure problems. Biofilms, slimy communities of bacteria, prevent heat transfer, cause massive corrosion, biofouling and diseases, while costing the US economy in the double-digit billion dollar figures. Current approaches to combat these persistent problems are either toxic, corrosive and/or environmentally damaging. Novophage is developing a first-in-class anti-biofilm solution that is green and highly effective against bio... films. Enabled by their expertise in synthetic biology and systems biology, their patent-pending solution utilizes a biological nanoparticle that leverages biofilm bacteriaโs own machinery to create active agents that act against the biofilm itself. This approach can be combined with existing antimicrobials to increase energy efficiency in heat transfer systems and prolong the lifetime of valuable infrastructure.
NOVOPHAGE
Industry:
Biotechnology Industrial Information Technology Infrastructure Renewable Energy
Founded:
2009-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.novophage.com
Total Employee:
11+
Status:
Closed
Total Funding:
5.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads Google Adsense For Domains
Founder
Investors List
MassChallenge
MassChallenge investment in Grant - Novophage
Official Site Inspections
http://www.novophage.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109

More informations about "Novophage"
Novophage - Crunchbase Company Profile & Funding
Novophage is developing a first-in-class anti-biofilm solution that is green and highly effective against biofilms. Enabled by their expertise in synthetic biology and systems biology, their โฆSee details»
Novophage - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
Novophage Overview - Salary.com
The trusted data and intuitive software your organization needs to get pay right. ... Novophage is developing a new class of biologics for a variety of industrial applications. The company's โฆSee details»
Novophage Company Profile: , Investments, Contact Information, โฆ
Novophage is a fast growing startup company at the intersection of Food and Biotech. Novophage, based in Boston, recently took in over $5M in funding from some of the most โฆSee details»
Novophage - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... Jun 1, 2011: Series A - Novophage โ obfuscated. obfuscated โ Nov 1, โฆSee details»
Novophage - Company Profile & Staff Directory - ContactOut
Novophage is a Biotechnology company located in 27 Drydock Ave., 2nd FL., Boston, MA 02210, US with 20 employees. Access Novophage's email format and Novophage staff directory for โฆSee details»
Annual Report on Novophage's Revenue, Growth, SWOT Analysis ...
Determine whether Novophage grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof โฆSee details»
Novophage Therapeutics, Inc. - CMOCRO
Novophage is providing the biological solutions for industrial infrastructure problems. Novophage is developing a first-in-class anti-biofilm solution that is green and highly effective against โฆSee details»
Brighter future for bacteria detection - MIT News
Mar 20, 2014 They funded their company, then called Novophage, through university business-plan competitions across the country, and outfitted nearly an entire lab with reused equipment โฆSee details»
Novophage is providing the biological solutions for industrial ...
Novophage is developing a first-in-class anti-biofilm solution that is green and highly effective against biofilms. Enabled by their expertise in synthetic biology and systems biology, their โฆSee details»
Novophage nabs $5.75M funding, names Rosenbloom as CEO
Jun 3, 2011 Novophage Inc., a startup that was known until March as Novophage Therapeutics Inc., has taken in $5.75 million in its first institutional funding round. The deal also brings on โฆSee details»
Michael Koeris' Journey from Grad Student to Entrepreneur
After a brief stint at the venture capital firm, Flagship Ventures, Koeris helped change Novophage's focus. The company went from developing therapeutics to developing phage โฆSee details»
Novophage - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Novophage is providing the biological solutions for industrial infrastructure problems. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. โฆSee details»
Chevron cleans up with Novophage - globalventuring.com
Jun 1, 2011 Novophage, a US-based anti-bacterial company, has reportedly raised $5.75m from a consortium including oil major Chevronโs corporate venturing unit. News provider Boston โฆSee details»
Novophage Lands Series A Round - PE Hub
May 31, 2011 BOSTON, MA โ June 1, 2011 โ Novophage, an early-stage technology company that is developing a new class of industrial biologics, announced today that it has completed a โฆSee details»
Biotech Start-up Wins Global Moot Corp - Inc.com
May 19, 2009 Novophage Theraputics from Boston University hopes to market technology that slows resistence to antibiotics.See details»
How much do Novophage employees make? | Salary.com
The estimated salary range of the Biotechnology industry where Novophage is located is between $93,376 and $119,708, and its average salary is about $105,997. The company's revenue is โฆSee details»
Novophage - Crunchbase
Novophage is providing the biological solutions for industrial infrastructure problems.See details»
Novophage Completes $5.7M Series A Financing - FinSMEs
May 31, 2011 Novophage, a Boston, MA-based early-stage technology company that develops a new class of biologics for different industrial applications, has completed a $5.7m Series A โฆSee details»
Novophage company overview, insights, and reviews | Lensa
Job alerts from Novophage. Never miss new job openings. Get Free Job Alerts No, I'm not interested. Company - Private. Small. Boston, MA, 02109. Scientific Research & Development โฆSee details»